(Q35214104)

7 August 2017

1 reference

title

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. (English)

1 reference

Adaptive radiation therapy

7 August 2017

main subject

0 references

1 reference

Alan Pollack

1

1 reference

7 August 2017

Alex Hanlon

2

1 reference

7 August 2017

Eric M Horwitz

3

1 reference

7 August 2017

Steven Feigenberg

4

1 reference

7 August 2017

Robert G Uzzo

5

1 reference

7 August 2017

Robert A Price

6

1 reference

7 August 2017

publication date

5 September 2003

1 reference

7 August 2017

published in

World Journal of Urology

1 reference

7 August 2017

volume

21

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

200-208

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-003-0356-x

7 August 2017

exact match

0 references

cites work

Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?

1 reference

12 December 2020

Prostate target volume variations during a course of radiotherapy.

1 reference

12 December 2020

Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy

1 reference

12 December 2020

Experience of ultrasound-based daily prostate localization.

1 reference

12 December 2020

A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer

1 reference

12 December 2020

Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer

1 reference

12 December 2020

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

12 December 2020

Intrafraction prostate motion during IMRT for prostate cancer

1 reference

12 December 2020

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

12 December 2020

Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology

1 reference

12 December 2020

Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era

1 reference

12 December 2020

Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers

1 reference

12 December 2020

Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate.

1 reference

12 December 2020

Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint

1 reference

12 December 2020

Short-course, intensity-modulated radiotherapy for localized prostate cancer.

1 reference

12 December 2020

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

12 December 2020

Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer

1 reference

12 December 2020

Dose response in prostate cancer with 8-12 years' follow-up

1 reference

12 December 2020

Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?

1 reference

12 December 2020

Feasibility of automatic marker detection with an a-Si flat-panel imager.

1 reference

12 December 2020

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

12 December 2020

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer

1 reference

12 December 2020

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

12 December 2020

Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma

1 reference

12 December 2020

Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions.

1 reference

12 December 2020

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial

1 reference

12 December 2020

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

1 reference

12 December 2020

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

1 reference

12 December 2020

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

12 December 2020

A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition

1 reference

12 December 2020

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

1 reference

12 December 2020

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

12 December 2020

Flat-panel cone-beam computed tomography for image-guided radiation therapy.

1 reference

12 December 2020

A comparison of ventilatory prostate movement in four treatment positions.

1 reference

12 December 2020

Organ motion and its management

1 reference

12 December 2020

Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques

1 reference

12 December 2020

Development of a semi-automatic alignment tool for accelerated localization of the prostate

1 reference

12 December 2020

Is the alpha/beta ratio for prostate cancer low?

1 reference

12 December 2020

Measurements and clinical consequences of prostate motion during a radiotherapy fraction.

1 reference

12 December 2020

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

12 December 2020

Prostate motion during standard radiotherapy as assessed by fiducial markers.

1 reference

12 December 2020

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

12 December 2020

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer

1 reference

12 December 2020

Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy.

1 reference

12 December 2020

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

12 December 2020

Respiratory-induced prostate motion: quantification and characterization.

1 reference

12 December 2020

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

12 December 2020

The effect of dose on local control of prostate cancer.

1 reference

12 December 2020

The Gleason score shift: score four and seven years ago.

1 reference

12 December 2020

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

12 December 2020

Measurement of intrafractional prostate motion using magnetic resonance imaging.

1 reference

12 December 2020

Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

1 reference

12 December 2020

Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).

1 reference

12 December 2020

Practical application of biochemical failure definitions: what to do and when to do it

1 reference

12 December 2020

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

12 December 2020

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

12 December 2020

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

12 December 2020

Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer

1 reference

12 December 2020

Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice

1 reference

12 December 2020

Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone

1 reference

12 December 2020

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.

1 reference

12 December 2020

Is alpha/beta for prostate tumors really low?

1 reference

12 December 2020

External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States

1 reference

12 December 2020

Optimization of conformal thoracic radiotherapy using cone-beam CT imaging for treatment verification.

1 reference

12 December 2020

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

1 reference

12 December 2020

The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?

1 reference

12 December 2020

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

12 December 2020

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

1 reference

12 December 2020

10.1007/S00345-003-0356-X

Identifiers

DOI

1 reference

7 August 2017

1 reference